Septerna Inc
Status: Publicly traded
Direct answer
Septerna Inc is publicly traded on NASDAQ under the ticker SEPN.
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric...
Can you invest in Septerna Inc?
Yes. Septerna Inc trades publicly on NASDAQ as SEPN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Septerna Inc
Detailed equity research is provided by MarketSnap.